PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets
ABSRACT Background Several studies have investigated the associations between the podocalyxin-like protein (PODXL) expression quantity or locations and cancers survival, but the results were far from conclusive. Therefore, we proceeded a meta-analysis on PODXL in various human cancers to find its pr...
Main Authors: | Siying He, Wenjie Du, Menglan Li, Ming Yan, Fang Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07108-5 |
Similar Items
-
Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset
by: Remy Nicolle, et al.
Published: (2019-01-01) -
Atypical focal segmental glomerulosclerosis associated with a new PODXL nonsense variant
by: David Marx, et al.
Published: (2021-05-01) -
Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets
by: Yingjie Shao, et al.
Published: (2017-03-01) -
Screening of Breast Cancer Methylation Biomarkers Based on the TCGA Database
by: Wang X, et al.
Published: (2021-12-01) -
Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy
by: Wei Zhang, et al.
Published: (2019-01-01)